Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] (EClinicalMedicine (2021) 37, (S2589537021002613), (10.1016/j.eclinm.2021.100981))